Dr. Chavanas is a INSERM senior researcher at Toulouse NeuroImaging Center (ToNIC, Toulouse, France). He has deep expertise in disease modeling, neural stem cells and inherited optic neuropathies. In his early works at INSERM, Thomas Jefferson University in Philadelphia and the Wellcome Trust Centre for Human Genetics in Oxford, Dr. Chavanas studied the genetics and pathophysiology of rare inherited skin diseases including Netherton syndrome, for which he discovered and studied the causative gene, SPINK5, and revealed its role in atopic dematitis. Those works paved the way to gene therapy approaches and enabled prenatal testing in numerous families over the past 20 years. At Toulouse Purpan Centre for Pathophysiology, Dr. Chavanas’ group provided key insight on the neuropathogeny of the congenital infection by human cytomegalovirus, the most common cause of brain congenital abnormalities, unraveling candidate severity factors. At ToNIC, Dr. Chavanas now develops innovative
human neural tissues models using stem cells and 3D bioprinting on microelectrode arrays. His group aims to implement an innovative bioprinted neuroretinal Interface for drug screening and athophysiological studies. Dr. Chavanas coordinates the consortium VISION, with clinicians and researchers in psychosociology, neuroimaging, microelectronics and disease modeling, and the patient association for optic neuropathies Ouvrir les Yeux.
Dr. Chavanas is a INSERM senior researcher at Toulouse NeuroImaging Center (ToNIC, Toulouse, France). He has deep expertise in disease modeling, neural stem cells and inherited optic neuropathies. In his early works at INSERM, Thomas Jefferson University in Philadelphia and the Wellcome Trust Centre for Human Genetics in Oxford, Dr. Chavanas studied the genetics and pathophysiology of rare inherited skin diseases including Netherton syndrome, for which he discovered and studied the causative gene, SPINK5, and revealed its role in atopic dematitis. Those works paved the way to gene therapy approaches and enabled prenatal testing in numerous families over the past 20 years. At Toulouse Purpan Centre for Pathophysiology, Dr. Chavanas’ group provided key insight on the neuropathogeny of the congenital infection by human cytomegalovirus, the most common cause of brain congenital abnormalities, unraveling candidate severity factors. At ToNIC, Dr. Chavanas now develops innovative
human neural tissues models using stem cells and 3D bioprinting on microelectrode arrays. His group aims to implement an innovative bioprinted neuroretinal Interface for drug screening and athophysiological studies. Dr. Chavanas coordinates the consortium VISION, with clinicians and researchers in psychosociology, neuroimaging, microelectronics and disease modeling, and the patient association for optic neuropathies Ouvrir les Yeux.